Literature DB >> 8346828

Malignant hyperthermia: a review of published cases.

K P Strazis1, A W Fox.   

Abstract

Malignant hyperthermia (MH) is triggered by many anesthetics. This study investigates the epidemiology of MH, its association with various drugs, and mortality rates. Five hundred three cases of MH were reported. MH patients were demographically similar worldwide. Pediatric (52.1%, age < 15 yr) and male (65.8%) MH patients exceed the general surgical population. Congenital defects and musculoskeletal surgical procedures were associated clearly with MH. Previous uneventful anesthesia (20.9%) and absence of positive family history (75.9%) were common. Case fatality rates have decreased with time to 10% since 1985. This decline is partly and independently due to dantrolene therapy, as well as to better vigilance and awareness on the part of the anesthetic community.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346828     DOI: 10.1213/00000539-199308000-00014

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  24 in total

1.  A case of malignant hyperthermia captured by an anesthesia information management system.

Authors:  Michael D Maile; Rajesh A Patel; James M Blum; Kevin K Tremper
Journal:  J Clin Monit Comput       Date:  2011-06-03       Impact factor: 2.502

2.  Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.

Authors:  I Moroni; E F Gonano; G P Comi; V Tegazzin; A Prelle; A Bordoni; N Bresolin; G Scarlato
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

3.  Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.

Authors:  A S Carr; J Lerman; M Cunliffe; M E McLeod; B A Britt
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

4.  Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.

Authors:  Phi T Ho; Brendan Carvalho; Eric C Sun; Alex Macario; Edward T Riley
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

Review 5.  Adverse effects of neuromuscular blockers and their antagonists.

Authors:  M Naguib; M M Magboul
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 6.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 7.  Ryanodine receptors: structure, expression, molecular details, and function in calcium release.

Authors:  Johanna T Lanner; Dimitra K Georgiou; Aditya D Joshi; Susan L Hamilton
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-20       Impact factor: 10.005

8.  Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.

Authors:  Marco Dainese; Marco Quarta; Alla D Lyfenko; Cecilia Paolini; Marta Canato; Carlo Reggiani; Robert T Dirksen; Feliciano Protasi
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

9.  RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia.

Authors:  Sherin Shaaban; Leigh Ramos-Platt; Floyd H Gilles; Wai-Man Chan; Caroline Andrews; Umberto De Girolami; Joseph Demer; Elizabeth C Engle
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

10.  Malignant hyperthermia developing during esophageal resection in an 82-year-old man.

Authors:  Norihito Nakamura; Tomomi Ueda; Reiri Ishikawa; Yosuke Tasaka; Kiyoshi Fukuuchi; Nobukazu Sato
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.